20671 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom Viruses; Subviral particles; Bacteriophages
Treating and preventing infections
#302LENTIVIRAL VECTORS IN HEMATOPOIETIC STEM CELLS TO TREAT WISKOTT-ALDRICH SYNDROME (WAS)
#303COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION
#304ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDE
#305SYNTHETIC RIG-I-LIKE RECEPTOR AGONISTS
#306PHAGE COMPOSITIONS COMPRISING CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#307COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION WITH A THERAPEUTIC INTERFERING PARTICLE
#308ANELLOVIRUS COMPOSITIONS AND METHODS OF USE
#309PREPARATION OF PHAGE COCKTAIL AS THERAPEUTIC AGENT FOR COW MASTITIS AND USE THEREOF
#310COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#311Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
#312THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS
#313Methods of treating bladder cancer
#314Bacteriophages for treatment of tuberculosis
#315COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF ENTEROTOXIGENIC BACTEROIDES FRAGILIS
#316Printed Delivery Device Having Supplements
#317APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE
#318HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
#319COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF ENTEROTOXIGENIC BACTEROIDES FRAGILIS
#320COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF ENTEROTOXIGENIC BACTEROIDES FRAGILIS
#321DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH
#322Replication-defective arenavirus vectors
#323NOVEL BACTERIOPHAGE AND THERAPEUTIC AGENT FOR BACTERIAL ENDOPHTHALMITIS
#324MODULAR PHAGE VECTOR PLATFORM FOR SONODYNAMIC THERAPY
#325METHODS OF TREATING BLADDER CANCER
#326GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS
#327FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#328COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
#329RETROVIRAL VECTORS
#330Gene Editing to Improve Joint Function
#331Bacteriophage Hydrogel Compositions and Uses Thereof
#332NOVEL CAMPYLOBACTER BACTERIOPHAGES AND USES THEREOF
#333METHOD FOR PRODUCING A MODIFIED BACTERIOPHAGE WITHOUT GENOME MODIFICATION
#334FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#335ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS
#336NANOVESICLES
#337COMPOSITIONS AND METHODS FOR TARGETING MULTINUCLEATED CELLS
#338SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
#339METHOD FOR TREATING MUSCULAR DYSTROPHY BY TARGETING DMPK GENE
#340MINIGENE THERAPY
#341AAV MUTANT THAT EFFICIENTLY INFECTS SUPPORTING CELLS
#342BACTERIOPHAGES FOR THE TREATMENT OF TUBERCULOSIS
#343VECTOR-BASED THERAPY FOR THYROID DISEASE
#344DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF
#345SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS
#346ENHANCEMENT OF POLYPEPTIDES AND CHIMERIC ANTIGEN RECEPTORS VIA HINGE DOMAINS
#347PRODUCTION OF LARGE-SIZED QUASIDYSTROPHINS USING OVERLAPPING AAV VECTORS
#348Methods And Compositions For Using Alternating Electric Fields In Gene Therapy
#349Method of treating, reducing, or alleviating a medical condition in a patient
#350COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASE TYPE III
#351COMPOSITIONS AND METHODS OF USING SENECA VALLEY VIRUS (SVV) FOR TREATING CANCER
#352RETROVIRAL VECTOR HAVING IMMUNE-STIMULATING ACTIVITY
#353REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#354RECOMBINANT AAV-CRUMBS HOMOLOGUE COMPOSITION AND METHODS FOR TREATING LCA-8 AND PROGRESSIVE RP
#355COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#356Methods and compositions for treating coronavirus infections
#357USE OF SPECIFIC PHAGES FOR THE TREATMENT OF NONTUBERCULOSIS MYCOBACTERIA (NTM) INFECTIONS
#358TREATMENT OF AGING OR AGE-RELATED DISORDERS USING XBP1
#359BACTERIOPHAGES FOR INHIBITING BACTERIA
#360Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
#361Destroying Cancer Cells While Maintaining Healthy Cell Integrity
#362Antibacterial and protective bacteriophage formulations and methods for making and using them
#363AN OPTIMIZED ACCEPTOR SPLICE SITE MODULE FOR BIOLOGICAL AND BIOTECHNOLOGICAL APPLICATIONS
#364DNA vaccine for human papillomavirus and method for using the same
#365Methods for treating microbial infections using caudovirales bacteriophages
#366METHODS OF TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH INCREASED TET LEVEL, INCREASED H19 LEVEL, INCREASED LEVEL OF TGF SIGNALING, OR ANY COMBINATION THEREOF
#367THERAPEUTIC METHODS INVOLVING GASTROINTESTINAL IMPLANTS
#368ARTIFICIAL VIRUS PRESENTING CELLS
#369BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE
#370BACTERIOPHAGE TREATMENT AND REDUCTION IN INFLAMMATORY RESPONSE
#371Adeno-Associated Virus Vector Formulations and Methods
#372NEUROPROTECTION OF NEURONAL SOMA AND AXON BY MODULATING ER STRESS/UPR MOLECULES
#373TREATMENT OF SANFILIPPO SYNDROME TYPE B
#374Methods and compositions for CNS delivery of heparan N-sulfatase
#375NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS
#376Method for purification of bacteriophage particles
#377COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#378EDIBLE WEB COMPRISING MICROORGANISMS
#379Targeted Phage for Bacterial Detection and Destruction
#380Multiple viral antigen COVID vaccine and therapeutic
#381COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS
#382COMPOSITIONS AND METHODS FOR INHIBITING THE PROLIFERATION OF PATHOGENIC ESCHERICHIA COLI
#383COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS
#384Methods of Identifying Bacteriophages that can Infect and Kill Host-Adapted Pathogenic Bacteria
#385OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
#386OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
#387AGENT FOR PROMOTING EXPRESSION OF N-ACETYLGALACTOSAMINYLTRANSFERASE CONTAINING EXTRACT FROM INFLAMED TISSUES INOCULATED WITH VACCINIA VIRUS
#388THERAPEUTIC BACTERIOPHAGES
#389BRANCHED RECEPTOR BINDING MULTI-SUBUNIT PROTEIN COMPLEXES FOR USE IN BACTERIAL DELIVERY VEHICLES
#390Methods and compositions for treating coronavirus infections
#391Immunoregulatory agent
#392AAV-IDUA vector for treatment of MPS I-associated blindness
#393IMPROVED LENTIVIRAL VECTOR
#394Methods and compositions for treating negative-sense single-stranded RNA virus
#395Methods of Treating Cancer
#396BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE
#397ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF
#398DELIVERY VEHICLE
#399Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#400RELAXIN RECEPTOR 1 FOR USE IN TREATMENT AND PREVENTION OF HEART FAILURE
#401Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L
#402METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING THE DEVELOPMENT OF FOOD ALLERGIES
#403Therapeutic agent for neurodegenerative disease
#404A METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER
#405Modified capsid proteins for enhanced delivery of parvovirus vectors
#406EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME
#407Methods for the Diagnosis and Treatment of Biofilm-Related Infections
#408Plant-produced chimaeric orbivirus VLPs
#409Bacteriophage therapy
#410Combination of viral superinfection therapy with subthreshold doses of nivolumab plus ipilimumab in chronic HBV patients
#411Optimized vector for delivery in microbial populations
#412ANTICANCER AGENT, PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, AND KIT
#413Compositions and methods for inhibiting the proliferation of pathogenic
#414NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF
#415METHODS OF TREATING TIM-3 ELEVATION
#416BACTERIOPHAGE TREATMENT AND REDUCTION IN INFLAMMATORY RESPONSE
#417Compositions and methods for enhancing visual function
#418BACTERIOPHAGE-DERIVED RECOMBINANT PROTEIN HAVING ANTIMICROBIAL ACTIVITY AGAINST PATHOGENIC GRAM-NEGATIVE BACTERIA
#419BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTIONS
#420SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS
#421Compositions and methods for inhibiting the proliferation of pathogenic
#422Retroviral and lentiviral vectors
#423AADC polynucleotides for the treatment of Parkinson's disease
#424MODULATING RENAL LYMPHATICS TO REGULATE BLOOD PRESSURE
#425BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION
#426bacteriophage Lac-GAP-3 and use thereof in inhibiting proliferation of bacteria
#427Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#428Bacteriophage-Based Antibodies and Binders
#429Compositions and methods for inhibiting the proliferation of pathogenic
#430Pharmaceutical composition based on bacteriophages against ; use in the treatment of diseases associated with this pathogen
#431VIRUS-LIKE PARTICLES WHICH CAN BE USED IN THE TREATMENT OF ALLERGIES
#432MODULATION OF mTORCI ACTIVITY AND AUTOPHAGY VIA CIB2-RHEB INTERACTION
#433TARGETED ELIMINATION OF BACTERIAL GENES
#434Treatment of topical and systemic bacterial infections
#435BACTERIOPHAGE PREPARATION
#436E. COLI BACTERIOPHAGE ESC-COP-14 AND USE THEREOF IN INHIBITING GROWTH OF PATHOGENIC E. COLI
#437Systems and Methods for Treating Patients Infected with SARS-COV-2
#438PD-1 and CTLA-4 Dual Inhibitor Peptides
#439Biased IL2 muteins methods and compositions
#440Methods for diagnosis and treatment of type 1 diabetes
#441Virus-like particles and use thereof
#442TREATMENT OF CARDIOMYOPATHY THROUGH MODULATION OF HYPOXIA-INDUCED eRNA ACTIVITY
#443Gene editing to improve joint function
#444COMPOSITIONS AND METHODS TO BARCODE BACTERIOPHAGE RECEPTORS, AND USES THEREOF
#445CAR EXPRESSION VECTOR AND CAR-EXPRESSING T CELLS
#446CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER
#447IMMUNOTHERAPY FOR CANCER
#448BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION
#449Gene editing to improve joint function
#450Immunogenic composition
#451REGULATABLE GENE EDITING COMPOSITIONS AND METHODS
#452Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor
#453METHODS AND COMPOSITION FOR CONTROLLING MAP INFECTION AND CONTAMINATION
#454Method for treating cancer using dengue virus serotype 1 (DENV-1)
#455SYSTEMS AND METHODS OF SPECTROPHOTOMETRY FOR THE DETERMINATION OF GENOME CONTENT, CAPSID CONTENT AND FULL/EMPTY RATIOS OF ADENO-ASSOCIATED VIRUS PARTICLES
#456MICROHOMOLOGY MEDIATED REPAIR OF MICRODUPLICATION GENE MUTATIONS
#457Phage therapy
#458MODIFIED AAV CONSTRUCTS AND USES THEREOF
#459SLC2A1 LNCRNA AS A BIOLOGIC AND RELATED TREATMENTS AND METHODS
#460Homogeneous engineered phage populations
#461ANTIBACTERIAL PHAGE, THERAPEUTIC COMPOSITION, BACTERICIDAL AGENT, FOOD, BACTERIA IDENTIFICATION KIT, THERAPEUTIC COMPOSITION MANUFACTURING METHOD, BACTERIA ELIMINATION METHOD, BACTERIA IDENTIFICATION METHOD, AND ANIMAL THERAPEUTIC METHOD
#462PRODUCTION METHODS FOR VIRAL VECTORS
#463Bacteriophage compositions and kits and related methods
#464COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
#465DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS
#466COCKTAIL COMPOSITIONS COMPRISING RESPIRATORY ANTIBACTERIAL PHAGES AND METHODS OF USE THEREOF
#467Products of manufacture and methods to enrich for and isolate viruses or phages capable of targeting specific microbes
#468BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS
#469NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-2, AND USE THEREOF FOR INHIBITING PROLIFERATION OF STREPTOCOCCUS SUIS STRAINS
#470Methods for treating or alleviating a bone-loss related disease or condition by administering a nucleic acid encoding a discoidin domain receptor 1 (DDR1) protein
#471NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-3, AND USE THEREOF FOR INHIBITING PROLIFERATION OF STREPTOCOCCUS SUIS STRAINS
#472NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-1 AND USE THEREOF IN INHIBITING STREPTOCOCCUS SUIS BACTERIUM PROLIFERATION
#473METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#474METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASES AND DISORDERS
#475COXSACKIE VIRUS B FOR TREATING TUMORS
#476COMPOSITIONS AND METHODS FOR TREATING DISEASES
#477Systems, Methods, and Compositions for Treating or Preventing Bacterial Infection and for Reducing or Preventing Bacterial Overpopulation
#478Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation
#479VIRAL VECTORS ENCODING RECOMBINANT FIX WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA B
#480COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES
#481Fast diagnosis and personalized treatments for acne
#482Interactional Biosystem
#483VIRUS-LIKE PARTICLE COMPOSITIONS AND METHODS OF USING SAME
#484BACTERIOPHAGE COMPOSITIONS
#485VECTOR-BASED ATTENUATED POXVIRUS VACCINES
#486LENTIVIRAL VECTOR FORMULATIONS
#487SHRNA EXPRESSION CASSETTE, POLYNUCLEOTIDE SEQUENCE CARRYING SAME, AND APPLICATION THEREOF
#488BIOMARKER AND TREATMENT TARGET FOR ALCOHOLIC HEPATITIS
#489Nanoscale coatings for encapsulation of biological entities
#490METHOD AND COMPOSITION FOR ENDOGENOUS PRODUCTION OF CONSTITUTIVELY ACTIVATED RECEPTORS, AND RECEPTORS WITH BROADER BINDING RANGES OR HIGHER AFFINITY THAN NATIVE RECEPTORS
#491Methods of treating bladder cancer with an oncolytic virus
#492bacteriophage Aer-HYP-3 and use thereof for inhibiting growth of bacteria
#493MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF
#494Therapeutic bacteriophage compositions for treating infection
#495Replication-defective arenavirus vectors
#496Phage therapy of infections
#497bacteriophage STP-2 and use thereof for inhibiting proliferation of
#498Pharmaceutical composition for treatment of diseases associated with upregulated periostin expression or periostin splice variant switching
#499Smallpox vaccine for cancer treatment
#500Microencapsulation of bacteriophages and related products
#501WIDE-SPECTRUM SALMONELLA PHAGE AND APPLICATION THEREOF
#502RECOMBINANT VIRAL VACCINES
#503CAPSID-MODIFIED RAAV VECTORS AND METHODS OF USE
#504COMBINATION THERAPY USING A CHIMERIC ANTIGEN RECEPTOR
#505TREATMENT OF TOPICAL AND SYSTEMIC BACTERIAL INFECTIONS
#506Adeno-associated virus virion for treatment of Tay-Sachs disease and Sandhoff disease
#507Compositions and methods for treating or preventing intestinal paracellular permeability
#508COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL CORD INJURY
#509METHODS FOR PROTECTING HAIR FOLLICLES
#510ONCOLYTIC VACCINIA VIRUS EXPRESSING IMMUNE CHECKPOINT BLOCKADE FOR CANCER IMMUNOTHERAPY
#511AAV6 VARIANTS
#512LENTIVIRAL VECTORS FOR HIGH-TITER TRANSDUCTION OF PRIMARY HUMAN CELLS
#513Bacteriophage composition and method of preventing bacterial infections in livestock
#514Methods for manufacturing T cells by direct sorting and compositions thereof
#515EXOSOME TARGETING OF CD4+ EXPRESSING CELLS
#516RETINOL-BINDING PROTEIN 3 (RBP3) AS A PROTECTIVE FACTOR IN NON-DIABETIC RETINAL DEGENERATION
#517Methods and compositions for CNS delivery of arylsulfatase A
#518USING INFECTIOUS NUCLEIC ACID TO TREAT CANCER
#519Optimized vector for delivery in microbial populations
#520Enhanced adoptive cell therapy
#521Lipin-1 as a novel therapy target of muscular dystrophy
#522COMPOSITIONS AND METHODS FOR TREATING MPSI
#523WOUND HEALING COMPOSITIONS
#524Protective interfering nucleic acid molecule and virus-like particle, viral vector, or virus particle containing the same as well as pharmaceutical composition containing the protective interfering nucleic acid and its use
#525Composition and a method for inhibiting the growth of pathogens causing bovine liver abscesses
#526MODIFIED FRIEDREICH ATAXIA GENES AND VECTORS FOR GENE THERAPY
#527Anti-angiogenin peptides, compositions, and methods of use
#528Brown fat-selective adipokines
#529AAV's and uses thereof
#530Phage dispensing system
#531Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof
#532Gene editing to improve joint function
#533METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS
#534Methods of treating amyotrophic lateral sclerosis (ALS)
#535Non-covalent loading of plant picovirus particles
#536Methods of CD40 and toll like receptor immune activation
#537Methods for combining adoptive T cell therapy with oncolytic virus adjunct therapy
#538Virus-like particles which can be used in the treatment of autoimmune diseases
#539COMBINATION THERAPIES FOR CANCER
#540MEDICATION FOR INFLUENZA
#541METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSE ASSOCIATED WITH AAV TRANSDUCTION
#542CRISPR-CAS GENOME ENGINEERING VIA A MODULAR AAV DELIVERY SYSTEM
#543Inhibitors of influenza virus replication and uses thereof
#544Substituted indoline derivatives as dengue viral replication inhibitors
#545Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer
#546Compositions and methods of treatment of Ehlers-Danlos syndromes
#547Variant AAV capsids for intravitreal delivery
#548Modified viral vectors and methods of making and using the same
#549Bacteriophage strains and their applications
#550AAV CAPSID DESIGNS
#551Compositions and methods related to xCT peptides
#552Synthetically enveloped virus
#553Gene therapies for lysosomal disorders
#554PREVENTIVE OR THERAPEUTIC AGENT FOR MUSCLE INJURY
#555Gene therapy for mucopolysaccharidosis IIIA
#556Engineered Herpes Simplex Virus-1 (HSV-1) vectors and uses thereof
#557Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
#558Gene therapy for mucopolysaccharidosis IIIB
#559Compositions and methods for treating Alzheimer's disease
#560Gene therapies for lysosomal disorders
#561Compositions and methods for diagnosing and treating peroxisomal diseases
#562Gene therapies for lysosomal disorders
#563Combination immunotherapies for treatment of cancer
#564Closed-ended, linear, duplex adenoassociated virus DNA, and uses thereof
#565Mutant virus, preparation method therefor and application thereof
#566Compositions and methods for treating leber's hereditary optic neuropathy
#567Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#568Use of a Syncytin for Targeting Drug and Gene Delivery to Regenerate Muscle Tissue
#569Combination Therapies of Hepatitis B Virus (HBV)-infected individuals using Parapoxvirus Ovis (PPVO) and at Least one Further Antiviral Drug
#570PHAGE AND TRANSDUCTION PARTICLES
#571Gene Therapy Constructs and Methods for Treatment of Hearing Loss
#572Optimized vector for delivery in microbial populations
#573SOD1 dual expression vectors and uses thereof
#574MiRNA Detargeting System for Tissue Specific Interference
#575Gene therapy for treating Mucopolysaccharidosis type II
#576Pharmaceutical composition for prevention or treatment of heart failure
#577Life-cycle-defective adenovirus helper viruses, their production and use for producing rAAV
#578BIOACTIVE PREPARATIONS SPECIFIC AGAINST VARIOLA VIRUS INFECTION MODEL STRAINS AND APPLICATIONS THEREOF
#579Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy
#580ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF
#581Genetically engineered coxsackievirus, and pharmaceutical composition
#582Dengue vaccine unit dose and administration thereof
#583Gene therapy for treating familial hypercholesterolemia
#584Methods to enhance myocardial regeneration and/or repair
#585Methods for treating and preventing diseases
#586Automated production of viral vectors
#587AAV vectors targeted to the central nervous system
#588Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
#589Bacteriophage and composition comprising same
#590Anellovirus compositions and methods of use
#591METHODS AND COMPOSITIONS FOR THE ACTIVATION OF TUMOR CYTOTOXICITY VIA HUMAN GAMMA-DELTA T-CELLS
#592Antifouling zwitterionic polymer coating and reverse coating method
#593METHODS AND IMMUNOGENIC COMPOSITIONS RELATING TO HER2 WITH SELECTIVE SEQUENCE MODIFICATIONS
#594Anticancer trail-targeted plant virus particles
#595Intrathecal delivery of recombinant adeno-associated virus encoding Methyl-CpG binding protein 2
#596SELECTIVE DESTRUCTION OF CELLS
#597Method for inducing production of vascular endothelial growth factor
#598Therapeutic bacteriophage compositions
#599APHERESIS METHODS AND USES
#600Oncolytic viral delivery of therapeutic polypeptides